{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:45:03Z","timestamp":1761871503754,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clml.2020.06.006","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T19:25:26Z","timestamp":1592076326000},"page":"e805-e808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Light Chain Deposition Disease in a Patient With MYD88 L265P Mutation-positive Low-grade B-cell Lymphoma and Monoclonal Immunoglobulin G \u03ba"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6504-9046","authenticated-orcid":false,"given":"Kentaro","family":"Narita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7892-4674","authenticated-orcid":false,"given":"Hiroki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Terawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-2196","authenticated-orcid":false,"given":"Yasuhito","family":"Suehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Matsue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.06.006_bib1","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2215\/CJN.10611110","article-title":"Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: Correlation with IgG subclass and response to rituximab","volume":"6","author":"Guiard","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clml.2020.06.006_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2215\/CJN.08640811","article-title":"Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution","volume":"7","author":"Nasr","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clml.2020.06.006_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","volume":"133","author":"Joly","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.06.006_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bjh.14279","article-title":"Renal disease related to Waldenstr\u00f6m macroglobulinemia: incidence, pathology and clinical outcomes","volume":"175","author":"Vos","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.06.006_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1470-2045(04)01495-0","article-title":"Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease","volume":"5","author":"Went","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2020.06.006_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1309\/AJCP8FOIVTB6LBER","article-title":"Lymphoplasmacytic lymphoma and other non \u2013 marginal zone lymphomas with plasmacytic differentiation","volume":"136","author":"Lin","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2020.06.006_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ajcp\/aqw072","article-title":"Lymphoplasmacytic lymphoma with a non-IgM paraprotein shows clinical and pathologic heterogeneity and may harbor MYD88 L265P mutations","volume":"145","author":"King","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2020.06.006_bib8","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3109\/10428194.2015.1096357","article-title":"Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression","volume":"57","author":"Cao","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.06.006_bib9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.06.006_bib10","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3324\/haematol.2019.227272","article-title":"MYD88 in the driver\u2019s seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications","volume":"104","author":"de Groen","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.06.006_bib11","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-18-0215","article-title":"MYD88 L265P mutation in lymphoid malignancies","volume":"78","author":"Yu","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2020.06.006_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00428-015-1858-9","article-title":"The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing","volume":"468","author":"Swerdlow","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clml.2020.06.006_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajh.20157","article-title":"Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement","volume":"77","author":"Asatiani","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.06.006_bib14","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1053\/j.ajkd.2015.10.007","article-title":"AJKD atlas of renal pathology: light chain deposition disease","volume":"66","author":"Fogo","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clml.2020.06.006_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/j.ajkd.2012.01.030","article-title":"Kidney biopsy teaching case cast nephropathy and light-chain deposition disease in Waldenstr\u00f6m macroglobulinemia","volume":"60","author":"Gnemmi","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clml.2020.06.006_bib16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1309\/QJ3PY18PMMJ8AYEH","article-title":"Detection by Immunofixation of M proteins in hypogammaglobulinemic patients with normal serum protein electrophoresis results","volume":"127","author":"Lakshminarayanan","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2020.06.006_bib17","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa1802917","article-title":"Phase 3 trial of ibrutinib plus rituximab in Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"378","author":"Leblond","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.06.006_bib18","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2016-10-747345","article-title":"Targeting Bruton tyrosine kinase with ibrutinib in relapsed\/refractory marginal zone lymphoma","volume":"129","author":"Noy","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.06.006_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1400376","article-title":"Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia","volume":"371","author":"Tam","year":"2014","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020303049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020303049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:35:38Z","timestamp":1761870938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020303049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2152265020303049"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.06.006","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Light Chain Deposition Disease in a Patient With MYD88 L265P Mutation-positive Low-grade B-cell Lymphoma and Monoclonal Immunoglobulin G \u03ba","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}